Tag: InMed Pharmaceuticals

0 750

InMed Pharmaceuticals Reports Third Quarter Fiscal 2021 Financial Results

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM), a clinical-stage company developing pharmaceutical-based drug candidates and…

 Leave a comment    Posted in LP News Tagged
0 676

InMed Pharmaceuticals to Report Third Quarter Fiscal 2021 Financial Results

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM; TSX:IN), a clinical-stage company developing pharmaceutical-based drug candidates…

 Leave a comment    Posted in Earnings, LP News Tagged ,